Cargando…
Betulinic Acid Affects the Energy-Related Proteomic Profiling in Pancreatic Ductal Adenocarcinoma Cells
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease with a 5-year survival rate of <8%. Therefore, finding new treatment strategies against PDAC cells is an imperative issue. Betulinic acid (BA), a plant-derived natural compound, has shown great potential to combat cancer owing to it...
Autores principales: | Chiu, Ching-Feng, Chang, Hsin-Yi, Huang, Chun-Yine, Mau, Chen-Zou, Kuo, Tzu-Ting, Lee, Hsiu-Chuan, Huang, Shih-Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123215/ https://www.ncbi.nlm.nih.gov/pubmed/33923185 http://dx.doi.org/10.3390/molecules26092482 |
Ejemplares similares
-
Quantitative Proteomic Analysis of Differentially Expressed Protein Profiles Involved in Pancreatic Ductal Adenocarcinoma
por: Kuo, Kung-Kai, et al.
Publicado: (2016) -
Proteome alterations in pancreatic ductal adenocarcinoma
por: Pan, Sheng, et al.
Publicado: (2020) -
Comparative Proteomic Profiling of Pancreatic Ductal Adenocarcinoma Cell Lines
por: Kim, Yikwon, et al.
Publicado: (2014) -
Proteomic analyses identify prognostic biomarkers for pancreatic ductal adenocarcinoma
por: Hu, Dingyuan, et al.
Publicado: (2018) -
Sorafenib in Combination with Betulinic Acid Synergistically Induces Cell Cycle Arrest and Inhibits Clonogenic Activity in Pancreatic Ductal Adenocarcinoma Cells
por: Kutkowska, Justyna, et al.
Publicado: (2018)